01241nas a2200361   4500000000100000008004100001260001300042653002600055653001200081653001900093653003100112653002100143653001100164653001200175653001500187653003000202653001300232653002700245653001800272100001500290700001600305700001300321700001600334700001200350700001400362700001100376245006700387856005600454300000900510490000700519520033900526022001400865       2014                            d  c2014 Jan10aAnti-Bacterial Agents10aDapsone10aDNA, Bacterial10aDrug Resistance, Bacterial10aGenes, Bacterial10aHumans10aleprosy10atratamento10apolymerase chain reaction10aRifampin10aSequence Analysis, DNA10aUnited States1 aScollard D1 aWilliams DL1 aGillis T1 aSandoval FG1 aLewis C1 aRobbins N1 aKeas S00aDrug resistance in patients with leprosy in the United States.  uhttps://academic.oup.com/cid/article/58/1/72/372994  a72-30 v583 a<p>Molecular drug susceptibility testing was performed on 39 US patients with leprosy. Of these, 2 had dapsone-resistant Mycobacterium leprae and 1 of these patients also had rifampin-resistant M. leprae. Even though antileprosy drug resistance occurs in this leprosy population, resistance does not appear to be a major problem. </p>  a1537-6591